The PE Ratio as of April 2025 (TTM) for Synlogic, Inc. (SYBX) is -0.60

According to Synlogic, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.60. This represents a change of -94.36% compared to the average of -10.64 of the last 4 quarters.

Synlogic, Inc. (SYBX) Historical PE Ratio (quarterly & annually)

How has SYBX PE Ratio performed in the past?

The mean historical PE Ratio of Synlogic, Inc. over the last ten years is -3.50. The current -0.60 PE Ratio has changed 1.61% with respect to the historical average. Over the past ten years (40 quarters), SYBX's PE Ratio was at its highest in in the June 2024 quarter at 2.26. The PE Ratio was at its lowest in in the September 2024 quarter at -38.92.

Synlogic, Inc. (SYBX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Synlogic, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Synlogic, Inc. (SYBX) Average PE Ratio

How has SYBX PE Ratio performed in the past?

The current PE Ratio of Synlogic, Inc. (SYBX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Synlogic, Inc. (SYBX) PE Ratio vs. Peers

How is SYBX’s PE Ratio compared to its peers?

Synlogic, Inc.’s PE Ratio is less than eFFECTOR Therapeutics, Inc. (-0.00), less than Galera Therapeutics, Inc. (-0.07), greater than Icosavax, Inc. (-15.78), greater than AC Immune SA (-2.97), greater than Protara Therapeutics, Inc. (-1.98), less than Vaccinex, Inc. (-0.07), greater than Monopar Therapeutics Inc. (-1.28), greater than Miromatrix Medical Inc. (-7.13), less than Surrozen, Inc. (-0.46), greater than Monte Rosa Therapeutics, Inc. (-4.41), greater than Stoke Therapeutics, Inc. (-6.00), greater than AN2 Therapeutics, Inc. (-0.75), less than Passage Bio, Inc. (-0.30), greater than 4D Molecular Therapeutics, Inc. (-1.09), less than Generation Bio Co. (-0.21), greater than Kronos Bio, Inc. (-0.60), greater than Erasca, Inc. (-20.25), greater than C4 Therapeutics, Inc. (-1.08), greater than Edgewise Therapeutics, Inc. (-10.64), less than Comera Life Sciences Holdings, Inc. (-0.00), less than SAB Biotherapeutics, Inc. (-0.41), less than Processa Pharmaceuticals, Inc. (-0.07), less than Fresh Tracks Therapeutics, Inc. (6.38), greater than Third Harmonic Bio, Inc. (-4.67),

Build a custom stock screener for Synlogic, Inc. (SYBX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Synlogic, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Synlogic, Inc. (SYBX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Synlogic, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.